The potential protective effect of tramiprosate (homotaurine) against Alzheimer’s disease: a review

@article{Caltagirone2012ThePP,
  title={The potential protective effect of tramiprosate (homotaurine) against Alzheimer’s disease: a review},
  author={C. Caltagirone and L. Ferrannini and N. Marchionni and G. Nappi and G. Scapagnini and M. Trabucchi},
  journal={Aging Clinical and Experimental Research},
  year={2012},
  volume={24},
  pages={580-587}
}
Due to the progressive aging of the population and to the age-associated increase in its incidence, Alzheimer’s disease (AD) will become in near future one of the major challenges that healthcare systems will have to face with in developed countries. Since the pathophysiological process of AD is thought to begin many years before the clinical diagnosis of dementia, in theory there is an opportunity for preventive therapeutic interventions. In recent years, there has been a growing interest… Expand

Paper Mentions

Observational Patient Registry Clinical Trial
This Observational protocol will attempt to verify two recent and very critical concepts in ALZ Clinical Research by studying high-risk individuals who already are taking medications… Expand
ConditionsAlzheimer Disease
InterventionBiological, Drug
Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
Exploitation of Marine Molecules to Manage Alzheimer's Disease.
Homotaurine in Parkinson’s disease
New Drugs from Marine Organisms in Alzheimer’s Disease
Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
Protective effect of centipedegrass against Aβ oligomerization and Aβ-mediated cell death in PC12 cells
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
A Phase 2 Study of Tramiprosate for Cerebral Amyloid Angiopathy
Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease
Alzheimer's disease
Immunology and immunotherapy of Alzheimer's disease
Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
Revising the definition of Alzheimer's disease: a new lexicon
...
1
2
3
4
5
...